Regenxbio Inc reported its latest earnings, revealing a shortfall of $0.38 compared to analysts' expectations. Additionally, the company's revenue did not meet projections, indicating a challenging financial period. The results have raised concerns among investors regarding the company's performance and future outlook. Further details regarding the specific figures and factors contributing to these results have yet to be disclosed.
Related Articles
Don't miss out on breaking stories and in-depth articles.